These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 3292151

  • 61. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R, Besarab A, Macdougall IC, Ellison DH, Maxwell AP, Sulowicz W, Klinger M, Rutkowski B, Correa-Rotter R, Dougherty FC, BA 16528 Study Investigators.
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [Abstract] [Full Text] [Related]

  • 62. Human recombinant erythropoietin: progress in clinical development.
    Kubiak W, Karwacki M, Mazur I.
    Ann Univ Mariae Curie Sklodowska Med; 1994 May; 48 Suppl 3():39-50. PubMed ID: 8192531
    [No Abstract] [Full Text] [Related]

  • 63. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
    Cermák J, Gregora E, Lachmanová J, Brabec V.
    Vnitr Lek; 1994 Mar; 40(3):174-8. PubMed ID: 8184571
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Blood pressure changes during treatment with recombinant human erythropoietin.
    Samtleben W, Baldamus CA, Bommer J, Fassbinder W, Nonnast-Daniel B, Gurland HJ.
    Contrib Nephrol; 1988 Mar; 66():114-22. PubMed ID: 3292144
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. [Ergometric results of r-erythropoietin treatment of hemodialysis patients].
    Hortian B, Schmidt R, Wüstenberg PW, Dörp E, Schumann L, Winkler R, Klinkmann H.
    Z Gesamte Inn Med; 1990 May 15; 45(10):274-7. PubMed ID: 2392856
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Daily self-administered subcutaneous erythropoietin: benefits in haemodialysis patients.
    Granolleras C, Branger B, Deschodt G, Shaldon S, Nonnast-Daniel B, Pollok M.
    Contrib Nephrol; 1990 May 15; 82():49-54. PubMed ID: 2093526
    [No Abstract] [Full Text] [Related]

  • 71. [Erythropoietin].
    Uhl D.
    Med Monatsschr Pharm; 1990 May 15; 13(5):130-1. PubMed ID: 2192242
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin.
    Eschbach JW.
    Kidney Int; 1989 Jan 15; 35(1):134-48. PubMed ID: 2651751
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. [The use of erythropoietin].
    Frenken LA, Koene RA.
    Ned Tijdschr Geneeskd; 1991 Feb 02; 135(5):163-6. PubMed ID: 2002863
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.